Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 2
2019 3
2020 3
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Case Report of an Unusual Tumor in an Adult With a TP53 Germline Mutation.
Castiaux J, Vandernoot I, Dallemagne J, Bruneau M, Delaunoy M, Peyrassol X, Heimann P, De Wilde V, Wolfromm A. Castiaux J, et al. Among authors: delaunoy m. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e645-e648. doi: 10.1016/j.clml.2020.10.001. Epub 2020 Dec 31. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34049842 No abstract available.
Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
D'Haene N, Le Mercier M, De Nève N, Blanchard O, Delaunoy M, El Housni H, Dessars B, Heimann P, Remmelink M, Demetter P, Tejpar S, Salmon I. D'Haene N, et al. Among authors: delaunoy m. PLoS One. 2015 Sep 14;10(9):e0138245. doi: 10.1371/journal.pone.0138245. eCollection 2015. PLoS One. 2015. PMID: 26366557 Free PMC article. Clinical Trial.
Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.
Seremet T, Jansen Y, Planken S, Njimi H, Delaunoy M, El Housni H, Awada G, Schwarze JK, Keyaerts M, Everaert H, Lienard D, Del Marmol V, Heimann P, Neyns B. Seremet T, et al. Among authors: delaunoy m. J Transl Med. 2019 Sep 5;17(1):303. doi: 10.1186/s12967-019-2051-8. J Transl Med. 2019. PMID: 31488153 Free PMC article.
Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy.
Seremet T, Planken S, Schreuer M, Jansen Y, Delaunoy M, El Housni H, Lienard D, Del Marmol V, Heimann P, Neyns B. Seremet T, et al. Among authors: delaunoy m. Melanoma Res. 2018 Feb;28(1):65-70. doi: 10.1097/CMR.0000000000000415. Melanoma Res. 2018. PMID: 29227333